- Thursday, August 29th 2019 at 15:00 - 16:00 UK (Other timezones)
- General participation info | Participate online | + Phone in United States (Toll Free): 1 877 309 2073 United States: +1 (571) 317-3129 Australia (Toll Free): 1 800 193 385 Australia: +61 2 8355 1020 Austria (Toll Free): 0 800 202148 Belgium (Toll Free): 0 800 78884 Canada (Toll Free): 1 888 455 1389 Denmark (Toll Free): 8090 1924 France (Toll Free): 0 805 541 047 Germany (Toll Free): 0 800 184 4222 Greece (Toll Free): 00 800 4414 3838 Hungary (Toll Free): (06) 80 986 255 Iceland (Toll Free): 800 9869 Ireland (Toll Free): 1 800 946 538 Israel (Toll Free): 1 809 454 830 Italy (Toll Free): 800 793887 Japan (Toll Free): 0 120 663 800 Luxembourg (Toll Free): 800 22104 Netherlands (Toll Free): 0 800 020 0182 New Zealand (Toll Free): 0 800 47 0011 Norway (Toll Free): 800 69 046 Poland (Toll Free): 00 800 1213979 Portugal (Toll Free): 800 819 575 Spain (Toll Free): 800 900 582 Sweden (Toll Free): 0 200 330 905 Switzerland (Toll Free): 0 800 740 393 United Kingdom (Toll Free): 0 800 169 0432 Access Code: 731-636-357
Over the past two decades, neuroimaging studies have defined a set of distributed brain systems that contribute to cognition, emotion, mood and other mental processes. Perturbations in these circuits have been identified in different ways across psychiatric disorders. The challenge ahead of us is how to use these insights to: 1) understand the nature of neural circuit deficits in mental illnesses and their relevance for existing treatments, and 2) to develop novel circuit-based therapeutics. I will discuss work in the lab defining the neural circuit abnormalities associated with psychiatric disorders as a whole, as well as specific changes associated with particular mood and anxiety disorders (and subgroups within them). I will then examine the mechanisms of current medication, psychotherapy and brain stimulation treatments within the context of a circuit-based understanding. Together, these data suggest that we are now on the brink of innovations in “rational” circuit-based diagnosis and treatments for mental illness. Success down this path will take us beyond use of symptom checklists for diagnosis, and one-size-fits all treatment with the psychopharmacological and psychotherapeutic tools currently available.
Amit Etkin
Associate Professor of Psychiatry and Behavioral Sciences
Stanford Neurosciences Institute
Stanford University
Investigator
VA Sierra-Pacific Mental Illness Research Education and Clinical Center (MIRECC)